While a common variant might increase the risk for autoimmune/inflammatory disorders or B-ALL today, it could have conferred protection to infections in the past, such as has been suggested for variants in TYK2, IKZF1, and FUT2 (110, 115). This evidence concerns the gene TYK2 and precursor B-cell acute lymphoblastic leukemia.